drug · small molecule
patient view →niraparib
Marketedupdated 2mo agoby $JNJ JOHNSON & JOHNSON🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and 26 investigational indications.
indications
investigational
NSCLC
targets
Poly [ADP-ribose] polymerase 2Poly [ADP-ribose] polymerase 1
all catalysts(5)
approval · 5
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that